(Q52652916)

5 May 2018

title

The programme to eliminate lymphatic filariasis in Orissa, India: the attitudes of some programme partners. (English)

1 reference

5 May 2018

0 references

1 reference

1

1 reference

5 May 2018

author name string

Nath N

series ordinal

2

1 reference

5 May 2018

publication date

1 October 2004

1 reference

5 May 2018

Annals of Tropical Medicine and Parasitology

published in

1 reference

5 May 2018

volume

98

1 reference

5 May 2018

issue

7

1 reference

5 May 2018

page(s)

751-757

1 reference

5 May 2018

Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India

cites work

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

Knowledge and beliefs about elephantiasis and hydrocele of lymphatic filariasis and some socio-demographic determinants in an endemic community of Eastern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

Evaluation of invermectin distribution in Benin, Côte d'Ivoire, Ghana and Togo: estimation of coverage of treatment and operational aspects of the distribution system

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

Mass treatment to eliminate filariasis in Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

The impact of the national polio immunization campaign on levels and equity in immunization coverage: evidence from rural North India

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

Re-assessing the global prevalence and distribution of lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

Lymphatic filariasis elimination: progress in global programme development

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

Onchocerciasis control in Uganda: how can self-sustaining, community-based treatment with ivermectin be achieved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

The role of albendazole in programmes to eliminate lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

Wolbachia bacteria of filarial nematodes: a target for control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225021433

10.1179/000349804225021433

21 January 2018

Identifiers

DOI

1 reference

5 May 2018

1 reference

5 May 2018